Drug Shortage Report for SANDOZ DONEPEZIL ODT
Report ID | 76174 |
Drug Identification Number | 02367696 |
Brand name | SANDOZ DONEPEZIL ODT |
Common or Proper name | DONEPEZIL ODT |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DONEPEZIL HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-02-12 |
Estimated end date | Unknown |
Actual end date | 2020-08-10 |
Shortage status | Resolved |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-11-17 | French | Compare |
v3 | 2023-11-17 | English | Compare |
v2 | 2019-02-18 | French | Compare |
v1 | 2019-02-18 | English | Compare |
Showing 1 to 4 of 4